콘텐츠로 건너뛰기
Merck

CR0003L200

Millipore

Single-use 3L stirred tank bioreactor (green)

로그인조직 및 계약 가격 보기

크기 선택


제품정보 (DICE 배송 시 비용 별도)

UNSPSC 코드:
23151806
eCl@ss:
32031690
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의

Quality Level

일반 설명

A single-use, stirred tank bioreactor designed for the non-GMP cultivation of mammalian cell lines. Its rigid design includes a semi-hemispherical shaped polycarbonate vessel, a multi-port high-density polyethylene (HDPE) headplate, a scoping marine impeller, both open pipe and sintered spargers, weldable C-Flex tubing, and all necessary gas inlet and outlet filters. Because the vessel is molded component, additional ports were added below the minimum working volume level including, one luer actuated sample port, one liquid inlet/outlet port, two liquid addition lines, direct sparging lines and a harvest line. All gas and liquid addition ports located below the minimum working volume incorporate check valves to ensure uni-directional flow of gas or liquid. The CellReady 3L Bioreactor is preassembled, gamma irradiated and shipped ready to use.

시험 성적서(COA)

제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

문서

High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.

This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.

This page describes the design attributes of the Cellicon® filter assembly for cell retention and how they simplify scale-up of intensified upstream processes.

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

모두 보기

관련 콘텐츠

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.